Skip to main content
PREVIEW · SAMPLE DATA
This is the MRVI dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for MRVI.

MRVI

MARAVAI LIFESCIENCES HOLDINGS, INC.
Life Sciences Tools & Services · Life Sciences Tools & Services
$292.21 sample
-1.91 (-0.65%) 1D
☆ Watch
Market cap
$244.1B
Price as of
2026-10-15
Latest filing
8-K
Alerts
8
Price$292.21 +11.94% 3M daily closessample
296.89257.23
2026-07-202026-08-112026-09-022026-09-232026-10-15
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 12INSInsider sell: Chief Financial Officer
  • Oct 07INSInsider sell: Director
  • Sep 30INSInsider sell: Chief Executive Officer
  • Sep 21INSInsider sell: 10% owner
  • Sep 11INSInsider buy: EVP, Operations
  • Sep 04INSInsider sell: Chief Financial Officer
  • Aug 28INSInsider sell: Chief Financial Officer
  • Aug 25INSInsider buy: Director
Sign up to see the real MRVI record →

Company facts

SEC EDGAR registration
Name
MARAVAI LIFESCIENCES HOLDINGS, INC.
Sector
Life Sciences Tools & Services
Industry
Life Sciences Tools & Services
Smart-money score
+35sample, -100 to +100
Reporting currency
USD

Who is positioning in MRVI

sample
Insiders
16 insider transactions over 90 days, net selling, $22.0M
Congress
2 members traded over 90 days
Institutions · 13F
22 funds hold $2.2B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$11.3B +15.0% y/y
Q4 2024Q3 2026
Inventory$6.9B +16.3% y/y
Q4 2024Q3 2026
Accounts receivable$5.0B +14.6% y/y
Q4 2024Q3 2026
Total debt$13.3B +8.0% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$49.9B +11.2% 3M
Sample peer B
$208.2B -1.5% 3M
Sample peer C
$216.1B +9.3% 3M
Sample peer D
$130.4B -7.9% 3M
Sample peer E
$71.8B +15.8% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not MRVI's real figure. Nothing here is investment advice.